Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Oxytocin and Masoprocol

supplement:

Oxytocin

supplement:

Masoprocol

Research Papers that Mention the Interaction

Intrauterine administration of nordihydroguaiaretic acid (NDGA) will maintain luteal function in sheep and also suppress the release of both oxytocin and prostaglandin F2 alpha (PGF2 alpha) suggesting that 5-lipoxygenase products of arachidonic acid may be involved in ovine luteolysis.
The Journal of endocrinology  •  1994  |  View Paper
Inhibition of the lipoxygenase metabolic pathway by nordihydroguaiaretic acid abolished AA-induced release of both OT and P4.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine  •  1992  |  View Paper
Mepacrine, NDHG and indomethacin also inhibited tonic contractions by OT in calcium-free EDTA treated medium.
Mepacrine, NDHGA and indomethacin, but not imidazol, inhibited in a dose-dependent way contractions induced by OT in the uterus.
Methods and findings in experimental and clinical pharmacology  •  1991  |  View Paper
Nordihydroguaiaretic acid , which inhibits 5-lipoxygenase, however, totally abolished arachidonic acid- and reduced PLA2-stimulated oxytocin secretion.
Endocrinology  •  1988  |  View Paper
3 Nordihydroguaiaretic acid , a lipoxygenase inhibitor, totally abolished the uterine response to either oxytocin or angiotensin II.
British journal of pharmacology  •  1983  |  View Paper